Netherlands· NL-84beffa2550b

Aggrastat 0,05 mg/ml oplossing, oplossing voor intraveneuze infusie

A tirofiban product containing tirofibanhydrochloride 1-water, registered in Netherlands by Advanz Pharma Limited. The same ATC class is registered in 11 of our 19 countries.

ATC B01AC17

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about tirofibanhydrochloride 1-waterAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Tirofiban is registered in 11 of 19 countries.

Countries holding a registration under ATC B01AC17 (tirofiban), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search tirofiban products by name

Tirofiban · ATC B01AC17

11 / 19 countries

Belgiumprice
Canada
Finlandprice
Franceprice
Germany
Netherlands
Norwayprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: TIROFIBANHYDROCHLORIDE 1-WATER
Manufacturer: Advanz Pharma Limited
Country: Netherlands (NL)
ATC code: B01AC17
ATC class: Tirofiban
Defined daily dose: 10 mg, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
23381

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

159 interactions on record for tirofiban.

Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check tirofiban against other medicines How interaction checks work

Tirofiban · interactions on record

159 records

62 severe
75 moderate
22 info

Most severe, free to view

DicoumarolB01AA01severe
WarfarinB01AA03severe
HeparinB01AB01severe
DalteparinB01AB04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tirofiban in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tirofiban products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

Austria · Aggrastat
Belgium · Aggrastat
Bulgaria · Аграстат, Тирофибан Чайкафарма
Cyprus · Aggrastat, Αggrafiban
Germany · Aggrastat, Tirofiban Ibisqus
Estonia · Aggrastat
Spain · Agrastat, Tirofiban Altan Pharmaceuticals S.A.
Finland · Aggrastat
France · Agrastat, Tirofiban Altan
United Kingdom (Northern Ireland) · Aggrastat, Tirofiban Eugia (Uk)
Greece · Aggrastat, Αggrafiban
Hungary · Aggrastat
Italy · Aggrastat, Tirofiban Aurobindo
Lithuania · Aggrastat
Luxembourg · Aggrastat
Latvia · Aggrastat
Malta · Aggrastat, Tirofiban Ibigen
Portugal · Tirofibano, Tirofibano Generis
Sweden · Aggrastat

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/9aef3bf3-a41f-453e-998b-8327f6d1de0a
GET /v1/drugs/9aef3bf3-a41f-453e-998b-8327f6d1de0a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h23381_smpc.pdf",
  "strength": null,
  "atc_label": "Tirofiban",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg23381",
  "excipients": [
    "CITROENZUUR 0-WATER (E 330)",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "TIROFIBANHYDROCHLORIDE 1-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h23381.pdf",
  "authorised_at": "1999/07/07",
  "procedure_number": "DE/H/0141/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "23381",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about tirofiban.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console